Luis V. Syro

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

Olivera Casar‐Borota, Philippe Chanson, Etienne Delgrange et al. · Endocrine Related Cancer · 2017 · 345 citations · Full text

Neuro-oncology, Anterior Pituitary, Pituitary Gland +14

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

Ann McCormack, Olaf M. Dekkers, Stephan Petersenn et al. · European Journal of Endocrinology · 2018 · 269 citations · Full text

Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis.

Soniya Sharma, Fateme Salehi, Bernd W. Scheithauer et al. · PubMed · 2009 · 150 citations

Unique Protein, Cancer Management, Pathology +17

Anti-VEGF therapy in pituitary carcinoma

León Darío Ortiz, Luis V. Syro, Bernd W. Scheithauer et al. · Pituitary · 2011 · 138 citations

Pituitary Gland, Medicine, Pathology +4

MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy

Kálmán Kovács, Bernd W. Scheithauer, Matilde Lombardero et al. · Acta Neuropathologica · 2007 · 117 citations

Pituitary Gland, Medicine, Immunology +7